Insulet (PODD) Common Equity (2010 - 2026)

Insulet (PODD) has reported Common Equity for 17 consecutive years, with $1.4 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Common Equity fell 2.78% year-over-year to $1.4 billion; the trailing twelve-month figure through Jun 2026 stood at $1.4 billion (down 2.78% YoY), and the FY2025 full-year result was $1.5 billion, up 25.06% from the prior year.
• Common Equity advanced to $1.4 billion in Q2 2026 per PODD's latest filing, from $1.3 billion in the prior quarter.
• Across five years, Common Equity topped out at $1.5 billion in Q4 2025 and bottomed at $422.4 million in Q2 2022.
• Historically, Common Equity has averaged $928.2 million across 5 years, with a median of $894.6 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Common Equity fell 23.68% in 2022, then jumped 84.03% in 2024.
• Over 5 years, Common Equity stood at $476.4 million in 2022, then soared by 53.8% to $732.7 million in 2023, then soared by 65.36% to $1.2 billion in 2024, then increased by 25.06% to $1.5 billion in 2025, then decreased by 6.14% to $1.4 billion in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $1.4 billion, $1.3 billion, and $1.5 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.